Pegylated interferon-α2a kinetics during experimental haemodialysis: impact of permeability and pore size of dialysersBARRIL, G; QUIROGA, J. A; SANZ, P et al.Alimentary pharmacology & therapeutics. 2004, Vol 20, Num 1, pp 37-44, issn 0269-2813, 8 p.Article

Experience with pegylated interferon α-2a in advanced myeloproliferative neoplasms in an international cohort of 118 patientsGOWIN, Krisstina; THAPALIYA, Prakash; CAMORIANO, John et al.Haematologica (Roma). 2012, Vol 97, Num 10, pp 1570-1573, issn 0390-6078, 4 p.Article

Interferon alpha for the adjuvant treatment of melanoma: review of international literature and practical recommendations from an expert panel on the use of interferonASCIERTO, Paolo A; CHIARION-SILENI, Vanna; MUGGIANO, Antonio et al.Journal of chemotherapy (Testo stampato). 2014, Vol 26, Num 4, pp 193-201, issn 1120-009X, 9 p.Article

Toxicity and bone marrow response of patients with hairy cell leukemia treated with biosynthetic (recombinant) α-2-interferonJACOBS, A. D; NAIEM, F; CHAMPLIN, R. E et al.Blut. 1985, Vol 50, Num 1, pp 33-34, issn 0006-5242Article

Human tolerance and histopathologic effects of long-term administration of intranasal interferon-α2HAYDEN, F. G; MILLS, S. E; JOHNS, M. E et al.The Journal of infectious diseases. 1983, Vol 148, Num 5, pp 914-921, issn 0022-1899Article

A psoriasiform drug eruption induced by polyethylene glycol interferon-alpha-2b, successfully treated by narrow band ultraviolet B therapyKUWABARA, Shinji; MAEJIMA, Hideki; WATARAI, Akira et al.EJD. European journal of dermatology. 2012, Vol 22, Num 1, pp 150-151, issn 1167-1122, 2 p.Article

Reduction in p48-ISGFγ levels confers resistance to Interferon-α_2a in MHCC97 cellsWU, Wei-Zhong; SUN, Hui-Chuan; GAO, Yan-Qin et al.Oncology. 2004, Vol 67, Num 5-6, pp 428-440, issn 0030-2414, 13 p.Article

Immunogenicity of biopharmaceuticals. The european perspectiveSCHELLEKENS, H; CASADEVALL, N.Developments in biologicals. 2003, Vol 112, pp 23-28, issn 1424-6074, 6 p.Article

Antiviral potency analysis and functional comparison of consensus interferon, interferon-α2a and pegylated interferon-α2b against hepatitis C virus infectionERICKSON, Andrea K; SEIWERT, Scott; GALE, Michael et al.Antiviral therapy (London). 2008, Vol 13, Num 7, pp 851-862, issn 1359-6535, 12 p.Article

Comparative efficacy of pegylated interferons α-2a and 2b in the treatment of HBeAg-negative chronic Hepatitis B infectionKARABAY, Oguz; TUNA, Nazan; ESEN, Saban et al.European journal of gastroenterology & hepatology. 2012, Vol 24, Num 11, pp 1296-1301, issn 0954-691X, 6 p.Article

Intratumoral Therapy With Interferon-α in a Locoregional Advanced Malignant Blue Nevus A Brief CommunicationVON MOOS, Roger; SCHAFFNER, Reto; CATHOMAS, Richard et al.Journal of immunotherapy (1997). 2010, Vol 33, Num 1, pp 92-95, issn 1524-9557, 4 p.Article

p53 protein expression in chronic hepatitis C; Effect of interferon alpha 2b therapyPANASIUK, Anatol; PROKOPOWICZ, Danuta; DZIECIOL, Janusz et al.Hepato-gastroenterology. 2005, Vol 52, Num 64, pp 1176-1179, issn 0172-6390, 4 p.Article

Transdermal delivery of interferon alpha-2B using microporation and iontophoresis in hairless rats : Transdermal delivery of proteinsBADKAR, Advait V; SMITH, Alan M; EPPSTEIN, Jonathan A et al.Pharmaceutical research. 2007, Vol 24, Num 7, pp 1389-1395, issn 0724-8741, 7 p.Article

48 weeks pegylated interferon alpha-2a is superior to 24 weeks of pegylated interferon alpha-2b in achieving hepatitis b e antigen seroconversion in chronic hepatitis B infectionHUT, C.-K; LAI, L. S. W; LAU, G. K. K et al.Alimentary pharmacology & therapeutics. 2006, Vol 23, Num 8, pp 1171-1178, issn 0269-2813, 8 p.Article

Pegylated interferons for the treatment of chronic hepatitis C infectionLUXON, Bruce A; GRACE, Michael; BRASSARD, Diana et al.Clinical therapeutics. 2002, Vol 24, Num 9, pp 1363-1383, issn 0149-2918, 21 p.Article

Thermal stability of the who international standard of interferon alpha 2b (IFN-α*2b): Application of new reporter gene assay for IFN-α2b potency determinationsCASERMAN, Simon; MENART, Viktor; DAS, Rose Gaines et al.Journal of immunological methods. 2007, Vol 319, Num 1-2, pp 6-12, issn 0022-1759, 7 p.Article

Fatal exacerbation of chronic hepatitis B induced by recombinant alpha-interferonMARCELLIN, P; COLIN, J.-F; BOYER, N et al.Lancet (British edition). 1991, Vol 338, Num 8770, issn 0140-6736, p. 828Article

Toxicity and exposure of an adenovirus containing human interferon alpha-2b following intracystic administration in cynomolgus monkeysVENEZIALE, R. W; KISHNANI, N. S; HUBBELL, J et al.Gene therapy (Basingstoke). 2012, Vol 19, Num 7, pp 742-751, issn 0969-7128, 10 p.Article

Percutaneous absorption of interferon-α by self-dissolving micropilesITO, Yukako; SAEKI, Atsushi; SHIROYAMA, Keiji et al.Journal of drug targeting. 2008, Vol 16, Num 3, pp 243-249, issn 1061-186X, 7 p.Article

Gene expression profiling and functional activity of human dendritic cells induced with IFN-α-2b: Implications for cancer immunotherapyMOSCHELLA, Federica; BISIKIRSKA, Brygida; MAFFEI, Antonella et al.Clinical cancer research. 2003, Vol 9, Num 6, pp 2022-2031, issn 1078-0432, 10 p.Article

Maintenance treatment with interferon alpha-2b in multiple myeloma : A prospective randomized study from PETHEMA (Program for the Study and Treatment of Hematological Malignancies, Spanish Society of Hematology)BLADE, J; SAN MIGUEL, J. F; ROZMAN, C et al.Leukemia. 1998, Vol 12, Num 7, pp 1144-1148, issn 0887-6924Article

Production of subtype-specific antipeptide antibodies to human interferon-α₁ and -α₄SATTAYASAI, N; HIBBS, A. R; MCMULLEN, G. L et al.Journal of interferon research. 1988, Vol 8, Num 3, pp 325-332, issn 0197-8357Article

Development of interferon alpha-2b microspheres with constant releaseZHIPING LI; LIN LI; YAN LIU et al.International journal of pharmaceutics (Print). 2011, Vol 410, Num 1-2, pp 48-53, issn 0378-5173, 6 p.Article

A scFv antibody fragment as a therapeutic candidate to neutralize a broad diversity of human IFN-alpha subtypesDEPETRIS, M; CASALIS, P; KRATJE, R et al.Journal of immunological methods. 2008, Vol 334, Num 1-2, pp 104-113, issn 0022-1759, 10 p.Article

Three-dimensional models of interferon-α subtypes IFN-conI, IFN-α₈, and IFN-α₁ derived from the crystal structure of IFN-α_2bWALTER, M. R.Seminars in oncology. 1997, Vol 24, Num 3, pp S9-52, issn 0093-7754, -S9-62, SUP9Conference Paper